Amanote Research

Amanote Research

    RegisterSign In

First Tissue-Agnostic Drug Approval Issued

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2017-078
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

June 5, 2017

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)


Related search

Debating Drug Approval Decisions

Cancer Discovery
Oncology
2013English

Elagolix: First Global Approval

Drugs
Pharmacology
2018English

Polatuzumab Vedotin: First Global Approval

Drugs
Pharmacology
2019English

Correction To: Ibalizumab: First Global Approval

Drugs
Pharmacology
2018English

Erratum To: Brodalumab: First Global Approval

Drugs
Pharmacology
2016English

Correction To: Delafloxacin: First Global Approval

Drugs
Pharmacology
2018English

Correction To: Camrelizumab: First Global Approval

Drugs
Pharmacology
2019English

Correction To: Polatuzumab Vedotin: First Global Approval

Drugs
Pharmacology
2019English

Congress Turns Spotlight on US Drug Approval Agency

Nature
Multidisciplinary
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy